Skip to main content
Log in

Four-weekly erythropoiesis-stimulating agent cost saving

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Darsonval A, et al. Cost-Minimisation Analysis of Erythropoiesis-Stimulating Agents in the Treatment of Anaemia in Dialysed Patients: A Pilot Study. PharmacoEconomics-Open : 9 Mar 2017. Available from: URL: http://dx.doi.org/10.1007/s41669-017-0016-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Four-weekly erythropoiesis-stimulating agent cost saving. PharmacoEcon Outcomes News 774, 16 (2017). https://doi.org/10.1007/s40274-017-3840-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-3840-z

Navigation